GLP-1 Coverage in 2027 Brings New Prices, New Options and Tougher Decisions
By Long Tran, PharmD; Beckie Fenrick, PharmD; and Jason Peterson, RPh GLP-1 coverage is becoming an even more complicated decision […]
By Long Tran, PharmD; Beckie Fenrick, PharmD; and Jason Peterson, RPh GLP-1 coverage is becoming an even more complicated decision […]
By Long Tran, PharmD; Beckie Fenrick, PharmD; and Jason Peterson, RPh A single cell or gene therapy can cost several
By Giorgio Vescera, Vice President of Underwriting and Analytics at Navion Your PBM just sent a proposal showing two separate
The third quarter brought new pharmacy developments for plan sponsors to watch, including approvals in COVID-19 prevention, cholesterol management, ADHD
By Beckie Fenrick, PharmD, MBA, Chief Pharmacy Officer, Navion A PBM proposal often arrives looking reassuringly precise. The discounts run
By Jason Peterson, RPh; Beckie Fenrick, PharmD; and Long Tran, PharmD As families prepare for a new school year, immunization records are back
By Beckie Fenrick, PharmD, MBA, Chief Pharmacy Officer at Navion Every major PBM has biosimilars on formulary. That doesn’t mean your groups are saving